MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $534,000 | – | 333,904 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |